Expression of transgenic FLIP on thyroid epithelial cells inhibits induction and promotes resolution of granulomatous experimental autoimmune thyroiditis in CBA/J mice

Endocrinology

Volumn 148, Issue 12, 2007, Pages 5734-5745

  Fang, Yujiang ^a   DeMarco, Vincent G ^a   Sharp, Gordon C ^a   Braley Mullen, Helen ^a,b  

^a University of Missouri   (United States)

^b WJB Dorn VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; FLICE INHIBITORY PROTEIN; THYROGLOBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNE THYROIDITIS; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CONTROLLED STUDY; DISEASE SEVERITY; EPITHELIUM CELL; FEMALE; FIBROSIS; GENE EXPRESSION REGULATION; GRANULOMATOSIS; IN VITRO STUDY; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECIPIENT; SPLEEN CELL; THYROID GLAND; TRANSGENE; UPREGULATION; WILD TYPE;

ANIMALS; ANTIGENS, CD3; APOPTOSIS; BLOTTING, WESTERN; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FORKHEAD TRANSCRIPTION FACTORS; MICE; MICE, INBRED CBA; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; T-LYMPHOCYTES; THYROID GLAND; THYROIDITIS, AUTOIMMUNE; THYROIDITIS, SUBACUTE;

EID: 36349022007     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0939     Document Type: Article

References (54)

1. Charreire J 1989 Immune mechanisms in autoimmune thyroiditis. Adv Immunol 46:263-334
2. Lira SA, Martin AP, Marinkovic T, Furtado GC 2005 Mechanisms regulating lymphocytic infiltration of the thyroid in murine models of thyroiditis. Crit Rev Immunol 25:251-262
3. Braley-Mullen H, Johnson M, Sharp GC, Kyriakos M 1985 Induction of experimental autoimmune thyroiditis in mice with in vitro activated splenic T cells. Cell Immunol 93:132-143
4. Conaway DH, Giraldo AA, David CS, Kong YC 1990 In situ analysis of T cell subset composition in experimental autoimmune thyroiditis after adoptive transfer of activated spleen cells. Cell Immunol 125:247-253
5. Braley-Mullen H, Sharp GC, Bickel JT, Kyriakos M 1991 Induction of severe granulomatous experimental autoimmune thyroiditis in mice by effector cells activated in the presence of anti-interleukin 2 receptor antibody. J Exp Med 173:899-912
6. Braley-Mullen H, Sharp GC, Tang H, Chen K, Kyriakos M, Bickel JT 1998 Interleukin-12 promotes activation of effector cells that induce a severe destructive granulomatous form of murine experimental autoimmune thyroiditis. Am J Pathol 152:1347-1358
7. Braley-Mullen H, Sharp GC 2000 Adoptive transfer murine model of granulomatous experimental autoimmune thyroiditis. Int Rev Immunol 19:535-555
8. Chen K, Wei Y, Sharp GC, Braley-Mullen H 2005 Balance of proliferation and cell death between thyrocytes and myofibroblasts regulates thyroid fibrosis in granulomatous experimental autoimmune thyroiditis (G-EAT). J Leukocyte Biol 77:166-172
9. Chen K, Wei Y, Sharp GC, Braley-Mullen H 2003 Mechanisms of spontaneous resolution versus fibrosis in granulomatous experimental autoimmune thyroiditis. J Immunol 171:6236-6243
10. + T cells. Cell Immunol 153:492-504
11. Chen K, Wei Y, Sharp GC, Braley-Mullen H 2000 Characterization of thyroid fibrosis in a murine model of granulomatous experimental autoimmune thyroiditis. J Leukocyte Biol 68:828-835
12. Stassi G, De Maria R 2002 Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat Rev Immunol 2:195-204
13. Stassi G, Di Liberto D, Todaro M, Zeuner A, Ricci-Vitiani L, Stoppacciaro A, Ruco L, Farina F, Zummo G, De Maria R 2000 Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins. Nat Immunol 1:483-488
14. Giordano C, Richiusa P, Bagnasco M, Pizzolanti G, Di Blasi F, Sbriglia MS, Mattina A, Pesce G, Montagna P, Capone F, Misiano G, Scorsone A, Pugliese A, Galluzzo A 2001 Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease. Thyroid 11:233-244
15. Semra YK, Seidi OA, Sharief MK 2001 Overexpression of the apoptosis inhibitor FLIP in T cells correlates with disease activity in multiple sclerosis. J Neuroimmunol 113:268-274
16. Tisch R, McDevitt H 1996 Insulin-dependent diabetes mellitus. Cell 85:291-297
17. Suvannavejh GC, Dal Canto MC, Matis LA, Miller SD 2000 Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis. J Clin Invest 105:223-231
18. Sabelko-Downes KA, Cross AH, Russell JH 1999 Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis. J Exp Med 189:1195-1205
19. Su X, Hu Q, Kristan JM, Costa C, Shen Y, Gero D, Matis LA, Wang Y 2000 Significant role for Fas in the pathogenesis of autoimmune diabetes. J Immunol 164:2523-2532
20. Itoh N, Imagawa A, Hanafusa T, Waguri M, Yamamoto K, Iwahashi H, Moriwaki M, Nakajima H, Miyagawa J, Namba M, Makino S, Nagata S, Kono N, Matsuzawa Y 1997 Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J Exp Med 186:613-618
21. Kang SM, Schneider DB, Lin Z, Hanahan D, Dichek DA, Stock PG, Baekkeskov S 1997 Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat Med 3:738-743
22. Mahiou J, Walter U, Lepault F, Godeau F, Bach JF, Chatenoud L 2001 In vivo blockade of the Fas-Fas ligand pathway inhibits cyclophosphamide- induced diabetes in NOD mice. J Autoimmun 16:431-440
23. Batteux F, Lores P, Bucchini D, Chiocchia G 2000 Transgenic expression of Fas ligand on thyroid follicular cells prevents autoimmune thyroiditis. J Immunol 164:1681-1688
24. Giordano C, Stassi G, De Maria R, Todaro M, Richiusa P, Papoff G, Ruberti G, Bagnasco M, Testi R, Galluzzo A 1997 Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275:960-963
25. Wei Y, Chen K, Sharp GC, Yagita H, Braley-Mullen H 2001 Expression and regulation of Fas and Fas ligand on thyrocytes and infiltrating cells during induction and resolution of granulomatous experimental autoimmune thyroiditis. J Immunol 167:6678-6686
26. Wei Y, Chen K, Sharp GC, Braley-Mullen H 2003 FLIP and FasL expression by inflammatory cells vs. thyrocytes can be predictive of chronic inflammation or resolution of autoimmune thyroiditis. Clin Immunol 108:221-233
27. Tang H, Chen K, Sharp GC, McKee L, Braley-Mullen H 2000 Apoptosis of thyrocytes and effector cells during induction and resolution of granulomatous experimental autoimmune thyroiditis. Int Immunol 12:1629-1639
28. Thome M, Tschopp J 2001 Regulation of lymphocyte proliferation and death by FLIP. Nat Rev Immunol 1:50-58
29. Budd RC, Yeh WC, Tschopp J 2006 cFLIP regulation of lymphocyte activation and development. Nat Rev Immunol 6:196-204
30. Kim YH, Kim S, Kim KA, Yagita H, Kayagaki N, Kim KW, Lee MS 1999 Apoptosis of pancreatic β-cells detected in accelerated diabetes of NOD mice: no role of Fas-Fas ligand interaction in autoimmune diabetes. Eur J Immunol 29:455-465
31. Lens SM, Kataoka T, Fortner KA, Tinel A, Ferrero I, MacDonald RH, Hahne M, Beermann F, Attinger A, Orbea HA, Budd RC, Tschopp J 2002 The caspase 8 inhibitor c-FLIP modulates T-cell receptor-induced proliferation but not activation-induced cell death of lymphocytes. Mol Cell Biol 22:5419-5433
32. Fang Y, Wei Y, DeMarco V, Chen K, Sharp GC, Braley-Mullen H 2007 Murine FLIP transgene expressed on thyroid epithelial cells promotes resolution of granulomatous experimental autoimmune thyroiditis. Am J Pathol 170:875-887
33. Chen K, Wei Y, Sharp GC, Braley-Mullen H 2002 Inhibition of TGFβ1 by anti-TGFβ1 antibody or lisinopril reduced thyroid fibrosis in granulomatous experimental autoimmune thyroiditis. J Immunol 169:6530-6538
34. Tang H, Sharp GC, Chen K, Braley-Mullen H 1998 The kinetics of cytokine gene expression in the thyroids of mice developing granulomatous experimental autoimmune thyroiditis. J Autoimmun 11:581-589
35. Tang H, Sharp GC, Peterson K, Braley-Mullen H 1998 IFN-γ-deficient mice develop severe granulomatous experimental autoimmune thyroiditis with eosinophil infiltration in thyroids. J Immunol 160:5105-5112
36. Watson ML, White AM, Campbell EM, Smith AW, Uddin J, Yoshimura T, Westwick J 1999 Anti-inflammatory actions of interleukin-13: suppression of tumor necrosis factor-alpha and antigen-induced leukocyte accumulation in the guinea pig lung. Am J Respir Cell Mol Biol 20:1007-1012
37. Harrington L, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT 2005 Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123-1132
38. Wang SH, Bretz JD, Phelps E, Mezosi E, Arscott PL, Utsugi S, Baker Jr JR 2002 A unique combination of inflammatory cytokines enhances apoptosis of thyroid follicular cells and transforms nondestructive to destructive thyroiditis in experimental autoimmune thyroiditis. J Immunol 168:2470-2474
39. Bretz JD, Arscott PL, Myc A, Baker Jr JR 1999 Inflammatory cytokine regulation of Fas-mediated apoptosis in thyroid follicular cells. J Biol Chem 274:25433-25438
40. Shevach EM 2000 Regulatory T cells in autoimmunity. Annu Rev Immunol 18:423-429
41. Gangi E, Vasu C, Cheatem D, Prabhakhar B 2005 IL-10 producing CD4+CD25+ regulatory T cells play a critical role in granulocyte macrophage colony stimulatory factor-induced suppression of experimental autoimmune thyroiditis. J Immunol 174:7006-7013
42. Tschopp J, Irmler M, Thome M 1998 Inhibition of Fas death signals by FLIPs. Curr Opin Immunol 10:552-558
43. Djerbi M, Abdul-Majid KB, Abedi-Valugerdi M, Olsson T, Harris RA, Grandien A 2003 Expression of the long form of human FLIP by retroviral gene transfer of hemopoietic stem cells exacerbates experimental autoimmune encephalomyelitis. J Immunol 170:2064-2073
44. Kataoka T 2005 The caspase-8 modulator c-FLIP. Crit Rev Immunol 25:31-58
45. Wang SH, Arscott P, Wu P, Baker Jr JR 2006 No apparent damage in the thyroid of transgenic mice expressing antiapoptotic FLIP. Thyroid 16:1-8
46. Wei Y, Chen K, Sharp GC, Braley-Mullen H 2004 Fas ligand is required for resolution of granulomatous experimental autoimmune thyroiditis. J Immunol 173:7615-7621
47. Barreiro R, Lucker G, Herndon J, Ferguson TA 2004 Termination of antigen-specific immunity by CD95 ligand (Fas ligand) and IL-10. J Immunol 173:1519-1525
48. Bonfoco E, Stuart PM, Brunner T, Lin T, Griffith TS, Gao Y, Nakajima H, Henkart PA, Ferguson TA, Green DR 1998 Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells. Immunity 9:711-720
49. Ferguson TA, Griffith TS 2006 A vision of cell death: Fas ligand and immune privilege 10 years later. Immunol Rev 213:228-238
50. Mitsiades N, Poulaki V, Mitsiades CS, Kautras DA, Chrousos GP 2001 Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseases. Trends Endocrinol Metab 12:384-390
51. Zhang XR, Zhang LY, Devadas S, Li L, Keegan AD, Shi YF 2003 Reciprocal expression of TRAIL and CD95L in Th1 and Th2 cells: role of apoptosis in T helper subset differentiation. Cell Death Differ 10:203-210
52. Zhang X, Brunner T, Carter L, Dutton RW, Rogers P, Bradley L, Sato T, Reed JC, Green D, Swain SL 1997 Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med 185:1837-1849
53. Vieira PL, Christensen JR, Minaee S, O'Neill EJ, Barrat FJ, Boonstra A, Barthlott, T, Stockinger B, Wraith DC, O'Garra A 2004 IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J Immunol 172:5986-5993
54. + regulatory T cells produce IL-10 to suppress IFN-γ production and proliferation of CD8 T cells. J Immunol 175:7093-7097